HUP0003784A2 - Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény - Google Patents

Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény

Info

Publication number
HUP0003784A2
HUP0003784A2 HU0003784A HUP0003784A HUP0003784A2 HU P0003784 A2 HUP0003784 A2 HU P0003784A2 HU 0003784 A HU0003784 A HU 0003784A HU P0003784 A HUP0003784 A HU P0003784A HU P0003784 A2 HUP0003784 A2 HU P0003784A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
premature labor
treating dysmenorrhea
dysmenorrhea
treating
Prior art date
Application number
HU0003784A
Other languages
English (en)
Inventor
William J. Bologna
Howard L. Levine
Dominique De Ziegler
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0003784(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of HUP0003784A2 publication Critical patent/HUP0003784A2/hu
Publication of HUP0003784A3 publication Critical patent/HUP0003784A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány egy <-adrenerg agonistát és egy bioadhezív hordozóttartalmazó készítményre vonatkozik. A készítmény előnyösen terbutalinttartalmaz polikarbofilben. A találmány szerinti készítmény lokálisanfájdalmas menstruáció vagy koraszülés kezelésére alkalmazható anélkül,hogy a szerek alkalmazásával járó káros mellékhatások fellépnének. Ó
HU0003784A 1997-09-12 1998-09-08 A pharmaceutical composition for treating dysmenorrhea and premature labor HUP0003784A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5878997P 1997-09-12 1997-09-12
US09/145,172 US6126959A (en) 1997-09-12 1998-09-01 Pharmaceutical composition for treating dysmenorrhea and premature labor
PCT/US1998/018538 WO1999013862A2 (en) 1997-09-12 1998-09-08 A pharmaceutical composition for treating dysmenorrhea and premature labor

Publications (2)

Publication Number Publication Date
HUP0003784A2 true HUP0003784A2 (hu) 2001-08-28
HUP0003784A3 HUP0003784A3 (en) 2001-12-28

Family

ID=26738031

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003784A HUP0003784A3 (en) 1997-09-12 1998-09-08 A pharmaceutical composition for treating dysmenorrhea and premature labor

Country Status (20)

Country Link
US (2) US6126959A (hu)
EP (1) EP1011632B1 (hu)
JP (1) JP2002503637A (hu)
KR (1) KR100575386B1 (hu)
CN (1) CN1186009C (hu)
AT (1) ATE253892T1 (hu)
AU (1) AU738460B2 (hu)
BR (1) BR9812134A (hu)
CA (1) CA2303339C (hu)
DE (1) DE69819748T2 (hu)
DK (1) DK1011632T3 (hu)
ES (1) ES2210813T3 (hu)
HK (1) HK1025055A1 (hu)
HU (1) HUP0003784A3 (hu)
IL (1) IL134564A0 (hu)
NO (1) NO329203B1 (hu)
NZ (1) NZ502926A (hu)
PT (1) PT1011632E (hu)
RO (1) RO120814B1 (hu)
WO (1) WO1999013862A2 (hu)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341737B2 (en) * 1997-06-11 2008-03-11 Kimberly-Clark Worldwide, Inc. Medicated tampon
US7344732B2 (en) * 2002-01-10 2008-03-18 Kimberly-Clark Worldwide, Inc. Medicated tampon
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
RU2310474C2 (ru) * 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
FR2841223B1 (fr) 2002-06-19 2004-10-15 Sleever Int Enveloppe d'emballage d'objets(s) en materiau thermoretractable a face interne ou externe essentiellement lisse
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
WO2005027939A1 (en) * 2003-08-21 2005-03-31 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
ATE486588T1 (de) * 2004-08-13 2010-11-15 Boehringer Ingelheim Int Tablettenformulierung mit verlängerter freisetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon, herstellungsverfahren und verwendung dafür
US7481815B2 (en) * 2004-09-23 2009-01-27 Synthes (U.S.A.) Coplanar X-ray guided aiming arm for locking of intramedullary nails
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US8992589B2 (en) 2007-12-03 2015-03-31 The Florida State University Research Foundation, Inc. Using light to regulate uterine contractions
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
GB2484977A (en) * 2010-10-29 2012-05-02 Biocopea Ltd Treatment of a Th-1 mediated disease
JP5986632B2 (ja) 2011-06-28 2016-09-06 メディシス ファーマシューティカル コーポレイション 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用
AU2016356884A1 (en) * 2015-11-16 2018-06-21 Fundación Para La Investigación Médica Aplicada Novel compounds as inhibitors of dna methyltransferases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
USD345211S (en) 1992-04-06 1994-03-15 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
USD375352S (en) 1994-03-14 1996-11-05 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
FR2720276B1 (fr) * 1994-05-24 1997-09-05 Christophe Boyer Nouvelle utilisation thérapeutique des agents bétamimétiques et médicament en contenant.
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2725343B1 (fr) * 1994-10-10 1998-01-02 Jean Claude Attali Complexe insecticide et parasiticide, et procede de desinsectisation et de destruction des ectoparasites
US5985861A (en) 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
CA2273206A1 (en) * 1996-11-29 1998-06-04 Monsanto Company Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
CA2303339A1 (en) 1999-03-25
US20020012677A1 (en) 2002-01-31
US6699494B2 (en) 2004-03-02
KR100575386B1 (ko) 2006-05-03
CA2303339C (en) 2006-12-12
IL134564A0 (en) 2001-04-30
WO1999013862A2 (en) 1999-03-25
AU738460B2 (en) 2001-09-20
BR9812134A (pt) 2000-07-18
DE69819748D1 (de) 2003-12-18
ES2210813T3 (es) 2004-07-01
DK1011632T3 (da) 2004-03-29
NO20001287L (no) 2000-03-10
JP2002503637A (ja) 2002-02-05
KR20010030588A (ko) 2001-04-16
CN1270514A (zh) 2000-10-18
ATE253892T1 (de) 2003-11-15
NO20001287D0 (no) 2000-03-10
EP1011632B1 (en) 2003-11-12
DE69819748T2 (de) 2004-09-30
RO120814B1 (ro) 2006-08-30
WO1999013862A3 (en) 1999-05-14
HK1025055A1 (en) 2000-11-03
NZ502926A (en) 2001-10-26
AU9131198A (en) 1999-04-05
US6126959A (en) 2000-10-03
HUP0003784A3 (en) 2001-12-28
NO329203B1 (no) 2010-09-13
CN1186009C (zh) 2005-01-26
PT1011632E (pt) 2004-03-31
EP1011632A2 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
HUP0003784A2 (hu) Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény
DE69531457D1 (en) Sulfonamide
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
FI972623A (fi) Progesteroniantagonisteina ja antiestrogeeneina vaikuttavia yhdisteitä käytettäväksi yhdessä naisilla raskaudenestoon
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
HUP9801227A3 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
SE9401540L (sv) Munhygienkomposition
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
HUP0100066A2 (hu) Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
DE69519040D1 (de) Zusammensetzung zur hygiene,prophylaxe und behandlung der mundhöhle
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
ZA966577B (en) Pharmaceutical composition.
DE69427116D1 (de) Verwendung von 4&#39;-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees